{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T00:11:09Z","timestamp":1767139869629,"version":"build-2238731810"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2018,1,22]],"date-time":"2018-01-22T00:00:00Z","timestamp":1516579200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Gynecol Obstet"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1007\/s00404-018-4673-0","type":"journal-article","created":{"date-parts":[[2018,1,21]],"date-time":"2018-01-21T23:54:14Z","timestamp":1516578854000},"page":"837-846","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["The use of PIPAC (pressurized intraperitoneal aerosol chemotherapy) in gynecological oncology: a statement by the German \u201cArbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarialkarzinom (AGO-OVAR)\u201d, the Swiss and Austrian AGO, and the North-Eastern German Society of Gynaecologic Oncology"],"prefix":"10.1007","volume":"297","author":[{"given":"A. M.","family":"Dueckelmann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Fink","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Harter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Heinzelmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Marth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Mueller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Reinthaller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Tamussino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Wimberger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Sehouli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,1,22]]},"reference":[{"key":"4673_CR1","doi-asserted-by":"crossref","first-page":"E359","DOI":"10.1002\/ijc.29210","volume":"136","author":"J Ferlay","year":"2015","unstructured":"Ferlay J, Soerjomataram I, Dikshit R et al (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136:E359\u2013E386","journal-title":"Int J Cancer"},{"issue":"288\u201394","key":"4673_CR2","first-page":"98","volume":"27","author":"OW Foley","year":"2013","unstructured":"Foley OW, Rauh-Hain JA, del Carmen MG (2013) Recurrent epithelial ovarian cancer: an update on treatment. Oncology (Williston Park) 27(288\u201394):98","journal-title":"Oncology (Williston Park)"},{"key":"4673_CR3","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1002\/cncr.24149","volume":"115","author":"A Bois du","year":"2009","unstructured":"du Bois A, Reuss A, Pujade-Lauraine E, Harter P, Ray-Coquard I, Pfisterer J (2009) Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: a combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials: by the Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarialkarzinom (AGO-OVAR) and the Groupe d\u2019Investigateurs Nationaux Pour les Etudes des Cancers de l\u2019Ovaire (GINECO). Cancer 115:1234\u20131244","journal-title":"Cancer"},{"key":"4673_CR4","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0039-6109(16)41440-4","volume":"58","author":"CT Griffiths","year":"1978","unstructured":"Griffiths CT, Fuller AF (1978) Intensive surgical and chemotherapeutic management of advanced ovarian cancer. Surg Clin North Am 58:131\u2013142","journal-title":"Surg Clin North Am"},{"key":"4673_CR5","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.ygyno.2011.02.014","volume":"121","author":"P Harter","year":"2011","unstructured":"Harter P, Muallem ZM, Buhrmann C et al (2011) Impact of a structured quality management program on surgical outcome in primary advanced ovarian cancer. Gynecol Oncol 121:615\u2013619","journal-title":"Gynecol Oncol"},{"key":"4673_CR6","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1200\/JCO.2002.20.5.1248","volume":"20","author":"RE Bristow","year":"2002","unstructured":"Bristow RE, Tomacruz RS, Armstrong DK, Trimble EL, Montz FJ (2002) Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis. J Clin Oncol 20:1248\u20131259","journal-title":"J Clin Oncol"},{"key":"4673_CR7","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1097\/IGC.0b013e31821b2568","volume":"21","author":"GC Stuart","year":"2011","unstructured":"Stuart GC, Kitchener H, Bacon M et al (2011) 2010 Gynecologic Cancer InterGroup (GCIG) consensus statement on clinical trials in ovarian cancer: report from the Fourth Ovarian Cancer Consensus Conference. Int J Gynecol Cancer 21:750\u2013755","journal-title":"Int J Gynecol Cancer"},{"key":"4673_CR8","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/S1470-2045(16)30376-X","volume":"17","author":"JA Ledermann","year":"2016","unstructured":"Ledermann JA, Harter P, Gourley C et al (2016) Overall survival in patients with platinum-sensitive recurrent serous ovarian cancer receiving olaparib maintenance monotherapy: an updated analysis from a randomised, placebo-controlled, double-blind, phase 2 trial. Lancet Oncol 17:1579\u20131589","journal-title":"Lancet Oncol"},{"key":"4673_CR9","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1056\/NEJMoa052985","volume":"354","author":"DK Armstrong","year":"2006","unstructured":"Armstrong DK, Bundy B, Wenzel L et al (2006) Intraperitoneal cisplatin and paclitaxel in ovarian cancer. N Engl J Med 354:34\u201343","journal-title":"N Engl J Med"},{"key":"4673_CR10","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1111\/j.1525-1438.2007.01163.x","volume":"18","author":"A Gadducci","year":"2008","unstructured":"Gadducci A, Conte PF (2008) Intraperitoneal chemotherapy in the management of patients with advanced epithelial ovarian cancer: a critical review of the literature. Int J Gynecol Cancer 18:943\u2013953","journal-title":"Int J Gynecol Cancer"},{"key":"4673_CR11","unstructured":"Wenzel L et al (2016) Patient-reported outcomes of a phase III clinical trial of bevacizumab with IV versus IP chemotherapy in ovarian, fallopian tube, and primary peritoneal carcinoma. NCI-supplied agent: bevacizumab. NCT011o67712, a GOG\/NRG trial. SGO 2016; Abstract 7"},{"key":"4673_CR12","unstructured":"Walker JL et al (2016) A phase III clinical trial of bevacizumab with IV versus IP chemotherapy in ovarian, fallopian tube, and primary peritoneal carcinoma. NCI-supplied agent: bevacizumab. NCT01167712, a GOG\/NRG trial (GOG 252). SGO 2016; Abstract 6 2016"},{"key":"4673_CR13","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s004649900010","volume":"14","author":"MA Reymond","year":"2000","unstructured":"Reymond MA, Hu B, Garcia A et al (2000) Feasibility of therapeutic pneumoperitoneum in a large animal model using a microvaporisator. Surg Endosc 14:51\u201355","journal-title":"Surg Endosc"},{"key":"4673_CR14","doi-asserted-by":"crossref","first-page":"3504","DOI":"10.1245\/s10434-013-3039-x","volume":"20","author":"W Solass","year":"2013","unstructured":"Solass W, Giger-Pabst U, Zieren J, Reymond MA (2013) Pressurized intraperitoneal aerosol chemotherapy (PIPAC): occupational health and safety aspects. Ann Surg Oncol 20:3504\u20133511","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"4673_CR15","first-page":"421","volume":"141","author":"ASW Oyais","year":"2016","unstructured":"Oyais ASW, Zieren J, Reymond MA, Giger-Pabst U (2016) Arbeitssicherheitsaspekte der intraperitonealen Druck-Aerosol-Chemotherapie (PIPAC): Best\u00e4tigung der Unbedenklichkeit. Zentralbl Chir 141(4):421\u2013424","journal-title":"Zentralbl Chir"},{"key":"4673_CR16","doi-asserted-by":"crossref","first-page":"6852749","DOI":"10.1155\/2017\/6852749","volume":"2017","author":"M Hubner","year":"2017","unstructured":"Hubner M, Teixeira Farinha H, Grass F et al (2017) Feasibility and safety of pressurized intraperitoneal aerosol chemotherapy for peritoneal carcinomatosis: a retrospective cohort study. Gastroenterol Res Pract 2017:6852749","journal-title":"Gastroenterol Res Pract"},{"key":"4673_CR17","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1007\/s00464-012-2148-0","volume":"26","author":"W Solass","year":"2012","unstructured":"Solass W, Hetzel A, Nadiradze G, Sagynaliev E, Reymond MA (2012) Description of a novel approach for intraperitoneal drug delivery and the related device. Surg Endosc 26:1849\u20131855","journal-title":"Surg Endosc"},{"key":"4673_CR18","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1007\/s00464-011-1964-y","volume":"26","author":"W Solass","year":"2012","unstructured":"Solass W, Herbette A, Schwarz T et al (2012) Therapeutic approach of human peritoneal carcinomatosis with Dbait in combination with capnoperitoneum: proof of concept. Surg Endosc 26:847\u2013852","journal-title":"Surg Endosc"},{"key":"4673_CR19","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1245\/s10434-013-3213-1","volume":"21","author":"WKR Solass","year":"2014","unstructured":"Solass WKR, M\u00fcrdter T, Giger-Pabst U, Strumberg D, Tempfer C, Zieren J, Schwab M, Reymond MA (2014) Intraperitoneal chemotherapy of peritoneal carcinomatosis using pressurized aerosol as an alternative to liquid solution: first evidence for efficacy. Ann Surg Oncol 21:553\u2013559","journal-title":"Ann Surg Oncol"},{"key":"4673_CR20","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1093\/jnci\/89.7.480","volume":"89","author":"RL Dedrick","year":"1997","unstructured":"Dedrick RL, Flessner MF (1997) Pharmacokinetic problems in peritoneal drug administration: tissue penetration and surface exposure. J Natl Cancer Inst 89:480\u2013487","journal-title":"J Natl Cancer Inst"},{"key":"4673_CR21","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/nrc1456","volume":"4","author":"CH Heldin","year":"2004","unstructured":"Heldin CH, Rubin K, Pietras K, Ostman A (2004) High interstitial fluid pressure\u2014an obstacle in cancer therapy. Nat Rev Cancer 4:806\u2013813","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"4673_CR22","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/s00464-017-5652-4","volume":"32","author":"A Bellendorf","year":"2018","unstructured":"Bellendorf A, Khosrawipour V, Khosrawipour T et al (2018) Scintigraphic peritoneography reveals a non-uniform 99mTc-Pertechnetat aerosol distribution pattern for Pressurized Intra-Peritoneal Aerosol Chemotherapy (PIPAC) in a swine model. Surg Endosc 32(1):166\u2013174","journal-title":"Surg Endosc"},{"issue":"4","key":"4673_CR23","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1007\/s00464-016-5174-5","volume":"31","author":"D Gohler","year":"2017","unstructured":"Gohler D, Khosrawipour V, Khosrawipour T et al (2017) Technical description of the microinjection pump (MIP(R)) and granulometric characterization of the aerosol applied for pressurized intraperitoneal aerosol chemotherapy (PIPAC). Surg Endosc 31(4):1778\u20131784","journal-title":"Surg Endosc"},{"key":"4673_CR24","doi-asserted-by":"crossref","first-page":"4595","DOI":"10.21873\/anticanres.11008","volume":"36","author":"V Khosrawipour","year":"2016","unstructured":"Khosrawipour V, Khosrawipour T, Falkenstein TA et al (2016) Evaluating the effect of micropump(c) position, internal pressure and doxorubicin dosage on efficacy of pressurized intra-peritoneal aerosol chemotherapy (PIPAC) in an ex vivo model. Anticancer Res 36:4595\u20134600","journal-title":"Anticancer Res"},{"key":"4673_CR25","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1007\/s00432-016-2234-0","volume":"142","author":"V Khosrawipour","year":"2016","unstructured":"Khosrawipour V, Khosrawipour T, Kern AJ et al (2016) Distribution pattern and penetration depth of doxorubicin after pressurized intraperitoneal aerosol chemotherapy (PIPAC) in a postmortem swine model. J Cancer Res Clin Oncol 142:2275\u20132280","journal-title":"J Cancer Res Clin Oncol"},{"key":"4673_CR26","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1097\/01.sla.0000218089.61635.5f","volume":"244","author":"P Esquis","year":"2006","unstructured":"Esquis P, Consolo D, Magnin G et al (2006) High intra-abdominal pressure enhances the penetration and antitumor effect of intraperitoneal cisplatin on experimental peritoneal carcinomatosis. Ann Surg 244:106\u2013112","journal-title":"Ann Surg"},{"key":"4673_CR27","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1097\/00001813-199607000-00016","volume":"7","author":"P Jacquet","year":"1996","unstructured":"Jacquet P, Stuart OA, Chang D, Sugarbaker PH (1996) Effects of intra-abdominal pressure on pharmacokinetics and tissue distribution of doxorubicin after intraperitoneal administration. Anticancer Drugs 7:596\u2013603","journal-title":"Anticancer Drugs"},{"key":"4673_CR28","first-page":"593","volume":"30","author":"VBA Khosrawipour","year":"2016","unstructured":"Khosrawipour VBA, Khosrawipour C, Hedayat-Pour Y et al (2016) Irradiation does not increase the penetration depth of doxorubicin in normal tissue after pressurized intra-peritoneal aerosol chemotherapy (PIPAC) in an ex vivo model. In Vivo 30:593\u2013597","journal-title":"In Vivo"},{"key":"4673_CR29","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.21873\/anticanres.11498","volume":"37","author":"V Khosrawipour","year":"2017","unstructured":"Khosrawipour V, Khosrawipour T, Hedayat-Pour Y et al (2017) Effect of whole-abdominal irradiation on penetration depth of doxorubicin in normal tissue after pressurized intraperitoneal aerosol chemotherapy (PIPAC) in a post-mortem swine model. Anticancer Res 37:1677\u20131680","journal-title":"Anticancer Res"},{"key":"4673_CR30","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1007\/BF02554625","volume":"30","author":"PH Sugarbaker","year":"1987","unstructured":"Sugarbaker PH, Kern K, Lack E (1987) Malignant pseudomyxoma peritonei of colonic origin. Natural history and presentation of a curative approach to treatment. Dis Colon Rectum 30:772\u2013779","journal-title":"Dis Colon Rectum"},{"key":"4673_CR31","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1097\/PPO.0b013e3181a58f30","volume":"15","author":"P Piso","year":"2009","unstructured":"Piso P, Glockzin G, von Breitenbuch P et al (2009) Patient selection for a curative approach to carcinomatosis. Cancer J 15:236\u2013242","journal-title":"Cancer J"},{"key":"4673_CR32","doi-asserted-by":"crossref","first-page":"e362","DOI":"10.1016\/S1470-2045(12)70210-3","volume":"13","author":"PH Sugarbaker","year":"2012","unstructured":"Sugarbaker PH, Ryan DP (2012) Cytoreductive surgery plus hyperthermic perioperative chemotherapy to treat peritoneal metastases from colorectal cancer: standard of care or an experimental approach? Lancet Oncol 13:e362\u2013e369","journal-title":"Lancet Oncol"},{"key":"4673_CR33","doi-asserted-by":"crossref","DOI":"10.1201\/b19409","volume-title":"Intraperitoneal cancer therapy: principles and practice","author":"WP Ceelen","year":"2015","unstructured":"Ceelen WP, Levine E (2015) Intraperitoneal cancer therapy: principles and practice. CRC Press, Boca Raton"},{"key":"4673_CR34","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.ygyno.2013.11.022","volume":"132","author":"CB Tempfer","year":"2014","unstructured":"Tempfer CB, Celik I, Solass W et al (2014) Activity of pressurized intraperitoneal aerosol chemotherapy (PIPAC) with cisplatin and doxorubicin in women with recurrent, platinum-resistant ovarian cancer: preliminary clinical experience. Gynecol Oncol 132:307\u2013311","journal-title":"Gynecol Oncol"},{"key":"4673_CR35","first-page":"4265","volume":"42","author":"RF Ozols","year":"1982","unstructured":"Ozols RF, Young RC, Speyer JL et al (1982) Phase I and pharmacological studies of adriamycin administered intraperitoneally to patients with ovarian cancer. Cancer Res 42:4265\u20134269","journal-title":"Cancer Res"},{"key":"4673_CR36","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1097\/00000421-198610000-00009","volume":"9","author":"FJ Gianola","year":"1986","unstructured":"Gianola FJ, Sugarbaker PH, Barofsky I, White DE, Meyers CE (1986) Toxicity studies of adjuvant intravenous versus intraperitoneal 5-FU in patients with advanced primary colon or rectal cancer. Am J Clin Oncol 9:403\u2013410","journal-title":"Am J Clin Oncol"},{"key":"4673_CR37","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1245\/s10434-012-2840-2","volume":"20","author":"A Blanco","year":"2013","unstructured":"Blanco A, Giger-Pabst U, Solass W, Zieren J, Reymond MA (2013) Renal and hepatic toxicities after pressurized intraperitoneal aerosol chemotherapy (PIPAC). Ann Surg Oncol 20:2311\u20132316","journal-title":"Ann Surg Oncol"},{"key":"4673_CR38","doi-asserted-by":"crossref","DOI":"10.1515\/9783110366617","volume-title":"Pressurized intraperitoneal aerosol chemotherapy (PIPAC)\u2014cancer under pressure","author":"MA Reymond","year":"2014","unstructured":"Reymond MA, Solass W (2014) Pressurized intraperitoneal aerosol chemotherapy (PIPAC)\u2014cancer under pressure. De Gruyter, Berlin"},{"key":"4673_CR39","unstructured":"http:\/\/www.awmf.org\/uploads\/tx_szleitlinien\/032-035-OLl_Ovarialkarzinom_2016-10.pdf. Accessed 28 Sept 2017"},{"key":"4673_CR40","doi-asserted-by":"crossref","first-page":"4187","DOI":"10.1200\/JCO.2006.09.7527","volume":"25","author":"V Mobus","year":"2007","unstructured":"Mobus V, Wandt H, Frickhofen N et al (2007) Phase III trial of high-dose sequential chemotherapy with peripheral blood stem cell support compared with standard dose chemotherapy for first-line treatment of advanced ovarian cancer: intergroup trial of the AGO-Ovar\/AIO and EBMT. J Clin Oncol 25:4187\u20134193","journal-title":"J Clin Oncol"},{"key":"4673_CR41","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1055\/s-0032-1328320","volume":"73","author":"P Harter","year":"2013","unstructured":"Harter P, Mahner S, Hilpert F et al (2013) Statement by the kommission OVAR of the AGO study group on the use of HIPEC (hyperthermic intraperitoneal chemotherapy) to treat primary and recurrent ovarian cancer. Geburtshilfe Frauenheilkd 73:221\u2013223","journal-title":"Geburtshilfe Frauenheilkd"},{"key":"4673_CR42","first-page":"2264","volume":"39","author":"GM Hahn","year":"1979","unstructured":"Hahn GM (1979) Potential for therapy of drugs and hyperthermia. Cancer Res 39:2264\u20132268","journal-title":"Cancer Res"},{"key":"4673_CR43","first-page":"1136","volume":"40","author":"RE Meyn","year":"1980","unstructured":"Meyn RE, Corry PM, Fletcher SE, Demetriades M (1980) Thermal enhancement of DNA damage in mammalian cells treated with cis-diamminedichloroplatinum(II). Cancer Res 40:1136\u20131139","journal-title":"Cancer Res"},{"key":"4673_CR44","first-page":"455","volume":"65","author":"DS Alberts","year":"1980","unstructured":"Alberts DS, Peng YM, Chen HS, Moon TE, Cetas TC, Hoeschele JD (1980) Therapeutic synergism of hyperthermia-cis-platinum in a mouse tumor model. J Natl Cancer Inst 65:455\u2013461","journal-title":"J Natl Cancer Inst"},{"key":"4673_CR45","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/bjc.1994.45","volume":"69","author":"G Los","year":"1994","unstructured":"Los G, van Vugt MJ, Pinedo HM (1994) Response of peritoneal solid tumours after intraperitoneal chemohyperthermia treatment with cisplatin or carboplatin. Br J Cancer 69:235\u2013241","journal-title":"Br J Cancer"},{"key":"4673_CR46","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1080\/09553009414551121","volume":"66","author":"M Akaboshi","year":"1994","unstructured":"Akaboshi M, Tanaka Y, Kawai K, Akuta K, Masunaga S, Ono K (1994) Effect of hyperthermia on the number of platinum atoms binding to DNA of HeLa cells treated with 195mPt-radiolabelled cis-diaminedichloroplatinum(II). Int J Radiat Biol 66:215\u2013220","journal-title":"Int J Radiat Biol"},{"key":"4673_CR47","first-page":"5101","volume":"48","author":"TS Herman","year":"1988","unstructured":"Herman TS, Teicher BA, Cathcart KN, Kaufmann ME, Lee JB, Lee MH (1988) Effect of hyperthermia on cis-diamminedichloroplatinum(II) (rhodamine 123)2[tetrachloroplatinum(II)] in a human squamous cell carcinoma line and a cis-diamminedichloroplatinum(II)-resistant subline. Cancer Res 48:5101\u20135105","journal-title":"Cancer Res"},{"key":"4673_CR48","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S0959-8049(97)00370-5","volume":"34","author":"PJ Vaart van de","year":"1998","unstructured":"van de Vaart PJ, van der Vange N, Zoetmulder FA et al (1998) Intraperitoneal cisplatin with regional hyperthermia in advanced ovarian cancer: pharmacokinetics and cisplatin-DNA adduct formation in patients and ovarian cancer cell lines. Eur J Cancer 34:148\u2013154","journal-title":"Eur J Cancer"},{"key":"4673_CR49","doi-asserted-by":"crossref","first-page":"4258","DOI":"10.1007\/s00464-015-4738-0","volume":"30","author":"H Jung do","year":"2016","unstructured":"do Jung H, Son SY, Oo AM et al (2016) Feasibility of hyperthermic pressurized intraperitoneal aerosol chemotherapy in a porcine model. Surg Endosc 30:4258\u20134264","journal-title":"Surg Endosc"},{"key":"4673_CR50","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1245\/s10434-016-5108-4","volume":"23","author":"T Kakchekeeva","year":"2016","unstructured":"Kakchekeeva T, Demtroder C, Herath NI et al (2016) In vivo feasibility of electrostatic precipitation as an adjunct to pressurized intraperitoneal aerosol chemotherapy (ePIPAC). Ann Surg Oncol 23:592\u2013598","journal-title":"Ann Surg Oncol"},{"key":"4673_CR51","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1002\/ijc.25423","volume":"127","author":"MM Heiss","year":"2010","unstructured":"Heiss MM, Murawa P, Koralewski P et al (2010) The trifunctional antibody catumaxomab for the treatment of malignant ascites due to epithelial cancer: results of a prospective randomized phase II\/III trial. Int J Cancer 127:2209\u20132221","journal-title":"Int J Cancer"},{"key":"4673_CR52","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/j.ejso.2015.06.001","volume":"41","author":"K Odendahl","year":"2015","unstructured":"Odendahl K, Solass W, Demtroder C et al (2015) Quality of life of patients with end-stage peritoneal metastasis treated with pressurized intraperitoneal aerosol chemotherapy (PIPAC). Eur J Surg Oncol 41:1379\u20131385","journal-title":"Eur J Surg Oncol"},{"key":"4673_CR53","doi-asserted-by":"crossref","first-page":"4596176","DOI":"10.1155\/2017\/4596176","volume":"2017","author":"H Teixeira Farinha","year":"2017","unstructured":"Teixeira Farinha H, Grass F, Kefleyesus A et al (2017) Impact of pressurized intraperitoneal aerosol chemotherapy on quality of life and symptoms in patients with peritoneal carcinomatosis: a retrospective cohort study. Gastroenterol Res Pract 2017:4596176","journal-title":"Gastroenterol Res Pract"},{"key":"4673_CR54","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1186\/s12957-016-1008-0","volume":"14","author":"R Girshally","year":"2016","unstructured":"Girshally R, Demtroder C, Albayrak N, Zieren J, Tempfer C, Reymond MA (2016) Pressurized intraperitoneal aerosol chemotherapy (PIPAC) as a neoadjuvant therapy before cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. World J Surg Oncol 14:253","journal-title":"World J Surg Oncol"},{"key":"4673_CR55","first-page":"6723","volume":"35","author":"CB Tempfer","year":"2015","unstructured":"Tempfer CB, Rezniczek GA, Ende P, Solass W, Reymond MA (2015) Pressurized Intraperitoneal aerosol chemotherapy with cisplatin and doxorubicin in women with peritoneal carcinomatosis: a cohort study. Anticancer Res 35:6723\u20136729","journal-title":"Anticancer Res"},{"key":"4673_CR56","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.ygyno.2015.02.009","volume":"137","author":"CB Tempfer","year":"2015","unstructured":"Tempfer CB, Winnekendonk G, Solass W et al (2015) Pressurized intraperitoneal aerosol chemotherapy in women with recurrent ovarian cancer: a phase 2 study. Gynecol Oncol 137:223\u2013228","journal-title":"Gynecol Oncol"},{"key":"4673_CR57","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/s12957-016-0892-7","volume":"14","author":"M Robella","year":"2016","unstructured":"Robella M, Vaira M, De Simone M (2016) Safety and feasibility of pressurized intraperitoneal aerosol chemotherapy (PIPAC) associated with systemic chemotherapy: an innovative approach to treat peritoneal carcinomatosis. World J Surg Oncol 14:128","journal-title":"World J Surg Oncol"},{"key":"4673_CR58","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1186\/s12885-016-2668-4","volume":"16","author":"GA Rezniczek","year":"2016","unstructured":"Rezniczek GA, Jungst F, Jutte H et al (2016) Dynamic changes of tumor gene expression during repeated pressurized intraperitoneal aerosol chemotherapy (PIPAC) in women with peritoneal cancer. BMC Cancer 16:654","journal-title":"BMC Cancer"},{"key":"4673_CR59","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/jnci\/95.2.105","volume":"95","author":"JB Trimbos","year":"2003","unstructured":"Trimbos JB, Parmar M, Vergote I et al (2003) International Collaborative Ovarian Neoplasm trial 1 and Adjuvant ChemoTherapy In Ovarian Neoplasm trial: two parallel randomized phase III trials of adjuvant chemotherapy in patients with early-stage ovarian carcinoma. J Natl Cancer Inst 95:105\u2013112","journal-title":"J Natl Cancer Inst"},{"key":"4673_CR60","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1245\/s10434-009-0357-0","volume":"16","author":"P Harter","year":"2009","unstructured":"Harter P, Hahmann M, Lueck HJ et al (2009) Surgery for recurrent ovarian cancer: role of peritoneal carcinomatosis: exploratory analysis of the DESKTOP I Trial about risk factors, surgical implications, and prognostic value of peritoneal carcinomatosis. Ann Surg Oncol 16:1324\u20131330","journal-title":"Ann Surg Oncol"},{"key":"4673_CR61","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1002\/bjs.10521","volume":"104","author":"F Grass","year":"2017","unstructured":"Grass F, Vuagniaux A, Teixeira-Farinha H, Lehmann K, Demartines N, Hubner M (2017) Systematic review of pressurized intraperitoneal aerosol chemotherapy for the treatment of advanced peritoneal carcinomatosis. Br J Surg 104:669\u2013678","journal-title":"Br J Surg"},{"key":"4673_CR62","first-page":"2309","volume":"35","author":"U Giger-Pabst","year":"2015","unstructured":"Giger-Pabst U, Solass W, Buerkle B et al (2015) Low-dose pressurized intraperitoneal aerosol chemotherapy (PIPAC) as an alternative therapy for ovarian cancer in an octogenarian patient. Anticancer Res 35:2309\u20132314","journal-title":"Anticancer Res"}],"updated-by":[{"DOI":"10.1007\/s00404-018-4715-7","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2018,2,14]],"date-time":"2018-02-14T00:00:00Z","timestamp":1518566400000}}],"container-title":["Archives of Gynecology and Obstetrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00404-018-4673-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-018-4673-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-018-4673-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,12]],"date-time":"2022-08-12T19:37:12Z","timestamp":1660333032000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00404-018-4673-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,22]]},"references-count":62,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["4673"],"URL":"https:\/\/doi.org\/10.1007\/s00404-018-4673-0","relation":{},"ISSN":["0932-0067","1432-0711"],"issn-type":[{"value":"0932-0067","type":"print"},{"value":"1432-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,22]]}}}